Association of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis

Fenfang Zou1, Jianpeng Zhang1, Guoan Xiang1

  • 1Department of Respiratory, The Third Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.

Insights

This meta-analysis found no significant link between MMP-9 -1562 C>T polymorphism and asthma. However, the MMP-9 Arg668Gln, rs17577 polymorphism may be a risk factor for asthma susceptibility.

Area of Science:

  • Genetics
  • Immunology
  • Respiratory Medicine

Background:

  • Matrix metalloproteinase-9 (MMP-9) plays a role in inflammatory processes.
  • Published data on MMP-9 polymorphisms and asthma susceptibility are inconclusive.
  • A comprehensive meta-analysis is needed for a precise estimation of the association.

Purpose of the Study:

  • To investigate the association between MMP-9 polymorphisms (-1562 C>T, rs3918242; Gln279Arg, rs17576; Arg668Gln, rs17577) and asthma susceptibility.
  • To provide a more precise estimation of these associations through meta-analysis.

Main Methods:

  • A systematic literature search was conducted in multiple databases (PubMed, Web of Science, EMBASE, Wanfang, CNKI).
  • Eligible studies involving asthma patients and controls were identified.
  • Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, and sensitivity analyses and publication bias tests were performed.

Main Results:

  • No significant association was found between the MMP-9 -1562 C>T (rs3918242) polymorphism and asthma susceptibility across all genetic models and subgroups.
  • A potential borderline significant association was observed for the Gln279Arg (rs17576) polymorphism in the allelic model (OR=1.11, 95% CI=1.00-1.22).
  • A highly significant association was observed for the Arg668Gln (rs17577) polymorphism in dominant, recessive, homozygote genotype, and allelic models, suggesting it as a risk factor.

Conclusions:

  • The MMP-9 -1562 C>T (rs3918242) polymorphism is not associated with asthma susceptibility.
  • The MMP-9 Arg668Gln (rs17577) polymorphism may represent a risk factor for asthma susceptibility.
  • Further research may be warranted to elucidate the role of specific MMP-9 polymorphisms in asthma pathogenesis.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Directing Effect of Substituents: meta-Directing Groups01:09

Directing Effect of Substituents: meta-Directing Groups

Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
5.9K